Indraprastha Medical Corporation Limited Stock price

Equities

INDRAMEDCO

INE681B01017

Healthcare Facilities & Services

Delayed NSE India S.E. 08:02:00 2024-03-28 am EDT 5-day change 1st Jan Change
171.4 INR +4.99% Intraday chart for Indraprastha Medical Corporation Limited -1.92% -0.64%
Sales 2022 8.88B 107M Sales 2023 10.99B 132M Capitalization 7.06B 84.79M
Net income 2022 586M 7.03M Net income 2023 862M 10.35M EV / Sales 2022 0.53 x
Net cash position 2022 607M 7.29M Net cash position 2023 1.24B 14.85M EV / Sales 2023 0.53 x
P/E ratio 2022
9.14 x
P/E ratio 2023
8.2 x
Employees 2,947
Yield 2022
4.28%
Yield 2023
3.89%
Free-Float 41.3%
More Fundamentals * Assessed data
Dynamic Chart
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2023 CI
India to probe Apollo Hospital Delhi's alleged links to 'cash for kidneys' scandal RE
India's Apollo Hospitals' operator rejects allegation of illegal kidney transplants RE
Indraprastha Medical Corporation Limited Announces Cessation of Jasmine Shah as Non-Executive Director & Chairman CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Indraprastha Medical Corporation Limited Announces Resignation of Udit Prakash Rai as Non-Executive - Non-Independent Director CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Indraprastha Medical Corporation Limited Recommends Dividend for the Financial Year 2022-23 CI
ICRA Gives AA Rating to Indraprastha Medical's Bank Financing MT
Indraprastha Medical Corporation Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Indraprastha Medical Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Indraprastha Medical Corporation Limited Approves Dividend on Equity Shares for the Financial Year Ended on 31 March, 2022 CI
Indraprastha Medical Corporation Limited Proposes Dividend for the Fiscal Year 2022 CI
More news
1 day+4.99%
1 week-1.92%
Current month-4.67%
1 month-7.65%
3 months-0.93%
6 months+4.48%
Current year-0.64%
More quotes
1 week
161.55
Extreme 161.55
179.90
1 month
154.50
Extreme 154.5
186.45
Current year
154.50
Extreme 154.5
203.70
1 year
76.10
Extreme 76.1
229.80
3 years
52.05
Extreme 52.05
229.80
5 years
28.00
Extreme 28
229.80
10 years
28.00
Extreme 28
229.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Compliance Officer 53 20-08-23
Members of the board TitleAgeSince
Director/Board Member 92 88-03-15
Director/Board Member 61 20-08-23
Director/Board Member 64 05-08-30
More insiders
Date Price Change Volume
24-03-28 171.4 +4.99% 138,150
24-03-27 163.2 -4.03% 262,781
24-03-26 170 -3.57% 158,476
24-03-22 176.4 +0.94% 132,882
24-03-21 174.7 +4.83% 118,014

Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT

More quotes
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. The Company provides various services, such as in-patients, out-patients and clinical services. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. Indraprastha Apollo Hospitals has various specialties, such as anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics and gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, ophthalmology, plastic and reconstructive surgery, respiratory and sleep medicine, rheumatology, spine surgery, urology and andrology.
More about the company
  1. Stock
  2. Equities
  3. Stock Indraprastha Medical Corporation Limited - NSE India S.E.